title: Mixed connective tissue disease with protein-losing enteropathy: discussion of the treatment strategy.
authors.affiliation: Division of Nephrology, Department of Internal Medicine, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei.
authors.forename: Chia-Ter
authors.initials: CT
authors.lastname: Chao
authors.forename: Chun-Ying
authors.initials: CY
authors.lastname: Lai
authors.forename: Pai-Ling
authors.initials: PL
authors.lastname: Chang
authors.forename: Hau-Shin
authors.initials: HS
authors.lastname: Wu
authors.forename: Vin-Cent
authors.initials: VC
authors.lastname: Wu
authors.forename: Wei-Jie
authors.initials: WJ
authors.lastname: Wang
mesh_terms: D000284:Administration, Oral; D000328:Adult; D018501:Antirheumatic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001379:Azathioprine / Q000008:administration & dosage / Q000627:therapeutic use*; D015897:Comorbidity; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008947:Mixed Connective Tissue Disease / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology*; D011504:Protein-Losing Enteropathies / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology*; D016896:Treatment Outcome
chemical_list: D018501:Antirheumatic Agents; D003520:Cyclophosphamide; D001379:Azathioprine